PINL:ZLDPF - Post by User
Post by
whytestockson Jun 07, 2024 8:45pm
![](https://assets.stockhouse.com/kentico-cms/0341-00/images/Sprite.svg#id_Post_Views_Icon)
56 Views
Post# 36078796
Zealand Pharma announces that Boehringer Ingelheim's survodu
Zealand Pharma announces that Boehringer Ingelheim's survodu Just In: $ZLDPF Zealand Pharma announces that Boehringer Ingelheim's survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosisCompany announcement - No. 30 / 2024 Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis News builds on previously announced primary e...
ZLDPF - Zealand Pharma announces that Boehringer Ingelheim's survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis